Operating Lease, Right-of-Use Asset of Evofem Biosciences, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Evofem Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Evofem Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $195,000, a 54% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Evofem Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $195,000 +$68,000 +54% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $214,000 +$100,000 +88% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $52,000 -$7,000 -12% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $89,000 -$17,000 -16% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $127,000 -$24,000 -16% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $114,000 -$3,186,000 -97% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $59,000 -$3,843,000 -98% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $106,000 -$4,300,000 -98% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $151,000 -$4,953,000 -97% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $3,300,000 -$1,737,000 -34% 30 Jun 2023 10-Q 14 Nov 2023 2023 Q3
Q1 2023 $3,902,000 -$1,085,000 -22% 31 Mar 2023 10-Q 16 Jun 2023 2023 Q1
Q4 2022 $4,406,000 -$989,000 -18% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $5,104,000 -$660,000 -11% 30 Sep 2022 10-Q 06 Jan 2023 2022 Q3
Q2 2022 $5,037,000 -$1,110,000 -18% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $4,987,000 -$1,506,000 -23% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $5,395,000 -$1,461,000 -21% 31 Dec 2021 10-K 27 Apr 2023 2022 FY
Q3 2021 $5,764,000 -$1,434,000 -20% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $6,147,000 +$1,132,000 +23% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $6,493,000 +$6,231,000 +2378% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $6,856,000 +$6,696,000 +4185% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $7,198,000 +$6,883,000 +2185% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $5,015,000 +$4,532,000 +938% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $262,000 -$383,000 -59% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $160,000 +$160,000 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 $315,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $483,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $645,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 07 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.